NEW DELHI – India is witnessing a sharp rise in the demand for obesity and diabetes medications, with urban populations ...

Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...

The health sector is witnessing notable developments, including the rising demand for obesity drugs in India as Eli Lilly and ...

Cipla expands into CNS and weight management segments, focusing on patient needs and innovation for long-term value.

Pharmaceutical giant Cipla plans to enter India's weight management sector, while also bolstering its central nervous system ...

Mumbai: Mumbai-based pharma giant Cipla is gearing up to make an entry into India's rapidly growing weight management market, ...

Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has ...

The demand for obesity drugs in India is surging as Eli Lilly and Novo Nordisk compete. A Pakistani startup sends prosthetics ...

Cipla Limited is planning to enter the weight management segment in India, announced the company’s MD and global CEO Umang ...

The booming uptake of anti-obesity drugs in India is further underscored by rising momentum of Eli Lilly's Mounjaro, which ...

The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...